JENOP GLOBAL HEALTHCARE FUND Ltd
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$500M
Investors
128
Min Invest
$250,000
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
What this filing shows
·Every sentence is a value as filed on SEC Form D
JENOP GLOBAL HEALTHCARE FUND Ltd is a Cayman Islands entity that first filed a Form D on October 30, 2014 and most recently amended it on February 17, 2026, describing itself as a hedge fund. The offering claims Rule 506(c), Section 3(c), Section 3(c)(7) and covers equity and pooled investment fund interests. JENOP GLOBAL HEALTHCARE FUND Ltd reported $500,371,688 sold from 128 investors in an offering of indefinite size as of the Form D filed February 17, 2026. The offering relies on Rule 506(c), so the issuer may advertise it but may sell only to investors it has verified as accredited. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $250,000. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $1,287 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is The Belvedere Building, 69 Pitts Bay Road, 2nd Floor, Pembroke, Bermuda HM08.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
5
latest Nov 26, 2024
Critical / warning
0 / 1
2 watch · 2 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
raising
Latest event Sold increase · Nov 26, 2024
SEC.govInvestor
- 5 filing events with values and deltas, latest 2024-11-26, and alerts on the next one
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Adviser of Record (Form ADV)
CRD 107959 · SEC-registered adviser · lists this fund on Schedule D 7.B.(1) as a hedge fund
Auditor named on Form ADV: Deloitte & Touche LLP · PCAOB-registered per the adviser
From the adviser's Form ADV as loaded from the SEC bulk data, joined on this issuer's Form D file number. Fund-level figures and the adviser's full fund roster are in the terminal.
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Geoffrey Manfred Lewis
Director · New York, NY
Thomas Haskins Davis
Director · Hamilton, D0
Kenneth Haskins Moore
Director · New York, NY
Optima Managers Haskins LLC
Promoter · New York, NY
Neil Haskins Glass
Director · Hamilton, D0
Questions About JENOP GLOBAL HEALTHCARE FUND Ltd
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is JENOP GLOBAL HEALTHCARE FUND Ltd?
JENOP GLOBAL HEALTHCARE FUND Ltd is a Cayman Islands entity that filed a Form D with the SEC on February 17, 2026 as a hedge fund. The filing claims Rule 506(c), Section 3(c), Section 3(c)(7) for an offering of equity and pooled investment fund interests.
Is JENOP GLOBAL HEALTHCARE FUND Ltd legit?
AltStreet does not rate legitimacy; it reports the public record. JENOP GLOBAL HEALTHCARE FUND Ltd filed a Form D with the SEC on February 17, 2026 claiming Rule 506(c), Section 3(c), Section 3(c)(7). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $500,371,688 sold to 128 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is JENOP GLOBAL HEALTHCARE FUND Ltd registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that JENOP GLOBAL HEALTHCARE FUND Ltd claimed Rule 506(c), Section 3(c), Section 3(c)(7) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has JENOP GLOBAL HEALTHCARE FUND Ltd raised?
JENOP GLOBAL HEALTHCARE FUND Ltd reported $500,371,688 sold from 128 investors in an offering of indefinite size as of the Form D filed February 17, 2026.
Who can invest in JENOP GLOBAL HEALTHCARE FUND Ltd?
The offering relies on Rule 506(c), so the issuer may advertise it but may sell only to investors it has verified as accredited. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $250,000.
What is the minimum investment in JENOP GLOBAL HEALTHCARE FUND Ltd?
The Form D lists $250,000 as the minimum investment accepted from any outside investor as of February 17, 2026. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling JENOP GLOBAL HEALTHCARE FUND Ltd and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $1,287 and finders' fees as $0. Form D allows these to be estimates.
Who is behind JENOP GLOBAL HEALTHCARE FUND Ltd?
The Form D lists 5 related persons: Geoffrey Manfred Lewis, director; Thomas Haskins Davis, director; Kenneth Haskins Moore, director; Optima Managers Haskins LLC, promoter; Neil Haskins Glass, director. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is JENOP GLOBAL HEALTHCARE FUND Ltd located?
The issuer's address on its SEC filings is The Belvedere Building, 69 Pitts Bay Road, 2nd Floor, Pembroke, Bermuda HM08. Its phone number of record is 4412928900. It is organized under the laws of Cayman Islands.
How long is the JENOP GLOBAL HEALTHCARE FUND Ltd offering open?
The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 14 amendments are on record for this CIK.
How large is JENOP GLOBAL HEALTHCARE FUND Ltd?
The issuer declined to disclose its net asset value range on the Form D, which the form permits.

Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
